NSE: COHANCE | BSE: 543064

Expensive Underperformer

Download real time

1039.40 -39.80 (-3.69%)

73.81% Gain from 52W Low

129.3K NSE+BSE Volume

NSE 19 May, 2025 9:52 AM (IST)

26,459.5

Market Cap

High in industry

0.5

Beta 1Year

Very Low volatility

Board Meeting

The next board meeting for Cohance Lifesciences Ltd. is on 28 May 2025 for the purpose of Audited Results See details

Cohance Lifesciences Ltd. News and Updates

Name: Latest research reports of Cohance Lifesciences Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Cohance Lifesciences Ltd.
Rating: 5
Author: ICICI Securities Limited

Keep track of all breaking news on Cohance Lifesciences Ltd. from all sources in a single place.

VOTE: Is Suven Pharmaceuticals Ltd. worth buying?

22 Votes:

Buy 63.64%

Sell 13.64%

Hold 22.73%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf